Previous Page
OCTOBER 2013
Transactions
129
GSG aSSEt GMBH & co. vERWaLtUnGS KG’S (oRco-GSG) StRUctURaL
oPtIMISatIon oF tHE > € 400 MIo. REaL EStatE PoRtFoLIo
Gehrke Zumbroich & Partner has advised GSG asset GmbH & co. verwaltungs KG (oRco-GSG) with regard to the structural optimisation of its real estate portfolio. With approx. 815,000 sqm oRco-GSG is a leading provider of office- and commercial spare in Berlin. the portfolio comprises space between 20-20.000 sqm for production, office, workshop or storage. the formerly state owned oRco-GSG has been acquired from Land Berlin in 2007 in the course of a privatization by a joint venture of oRco Property Group and Morgan Stanley.
After a refinancing agreement for EUR 269,6 million. could be signed inter alia with the assistance of Gehrke Zumbroich & Partner in December 2012 with a banking club of five German banks, Gehrke Zumbroich & Partner now ad- vised the company in a complex transaction, which comprised the transfer of the complete real estate portfolio to several subsidiaries, especially to fa- cilitate future refinancing.
The team of Gehrke Zumbroich & Partner, which advised ORCO-GSG in the complete transaction, was led by Matthias Gehrke, naming partner of the firm.
Gehrke commented: “Already in the end of 2012 the refinancing of the expired € 304 mio. RBS loan agreement has been closed successfully. Now, the also successfully closed restructuring allows ORCO-GSG to focus only on the operative business for several years. The privatisation of the former land owned GSG has already been a success story. This may, now, continue and we are proud having supported our client in this regard.” LM
! ! !
SoHo FLoRdIS IntERnatIonaL acqUIRES PRotHERa
Soho Flordis International (SFI), an international provider of clinically proven natural medicines, announced recently the acquisitions of Ginsana and Prothera.
Ginsana from Pharmaton, is a Swiss based leader and innovator in natural medicines and ProThera is a specialist US nutraceutical company. The acquisitions mark an important milestone in establishing SFI as the leading global provider of clinically proven natural medicine.
With superior expertise, state-of-the-art manufacturing facilities and a complementary line of six natural medicine brands with significant growth potential, Ginsana helps SFI advance an extensive product portfolio and new product pipeline through a strong network of international distributors. These capabilities will enhance SFI’s Mission to give healthcare professionals and patients access to the best natural medicines supported by clinical studies. Ginsana will continue to market its products under the Ginsana brand name and manufacture world class natural medicines. The trademark rights of Pharmaton® remain at Pharmaton.
ProThera has over 50 years of formulation experience and a comprehensive product line of probiotics and dietary supplements distributed exclusively by healthcare providers. ProThera gives SFI entry into both the growing field of probiotics and the US market, further delivering on its mission to give healthcare providers and patients access to the best natural medicine supported by clinical studies.
“The parallel acquisitions of Ginsana and ProThera has not only extended our network and pipeline of natural medicine brands with great legacy, it allows us to enter into the attractive field of probiotics,” said SFI CEO, Nigel Pollard. LM
ORCO-GSG
ProThera